Adjournment of Annual Meeting to 1 October 2026
MyCelx Technologies Corporation
17 September 2026
17 September 2026
MYCELX Technologies Corporation
("MYCELX" or the "Company") (AIM: MYX or MYXR)
Adjournment of Annual Meeting to 1 October 2026
MYCELX announces that the Annual Meeting convened for 17 September 2026 at the offices of Cavendish Capital Markets Limited, One Bartholomew Close, London EC1A 7BL was opened. However, a quorum was not present in accordance with the Company’s Bylaws, which require the presence (in person or by proxy) of shareholders holding in excess of 50 per cent. of the Company’s total issued share capital.
The Company has received 11,320,446 votes, representing approximately 46.5 per cent. of its total issued share capital, all of which were voted in favour of the resolutions to be proposed at the Annual Meeting.
In the absence of a quorum, and in accordance with the Company’s Bylaws, the meeting was adjourned shortly after commencement.
The adjourned Annual Meeting will be held at 1650 International Court, Suite 100, Norcross, Georgia 30093, U.S.A. at 9.00 a.m. (EST) / 2.00p.m. (London time) on 1 October 2026.
For further information please contact:
|
Tel: +1 888 306 6843
Tel: +44 20 7220 0500 |
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.